Stock listing

GLUE Stock Price, News, Filings & Events — Monte Rosa Therapeutics, Inc.

Selected listing: GLUE · BOATS · USD · US

This page tracks Monte Rosa Therapeutics, Inc.'s GLUE:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GLUE:BOATS. GLUE:BOATS is the stock-level entry point for investors researching Monte Rosa Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Monte Rosa Therapeutics, Inc. is a public company traded under the ticker GLUE in the American market. The company has a market capitalization of approximately $1.92 billion. Monte Rosa focuses on developing innovative therapies to address unmet medical needs.

GLUE:BOATSUSDUSUpdated September 11, 2026
Monte Rosa Therapeutics, Inc. logo
Ticker
GLUE:BOATS
Asset type
Stock
Market cap
$1.20B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Monte Rosa Therapeutics, Inc. GLUE:BOATS stock context

This page tracks Monte Rosa Therapeutics, Inc.'s GLUE:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GLUE:BOATS. GLUE:BOATS is the stock-level entry point for investors researching Monte Rosa Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Monte Rosa Therapeutics, Inc. is a public company traded under the ticker GLUE in the American market. The company has a market capitalization of approximately $1.92 billion. Monte Rosa focuses on developing innovative therapies to address unmet medical needs.

Latest news from Monte Rosa Therapeutics, Inc.

All Monte Rosa Therapeutics, Inc. news →

Monte Rosa Therapeutics, Inc. earnings calls

Research Monte Rosa Therapeutics, Inc.

Alternate listings